810332 | 18:1 PE CF
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(carboxyfluorescein) (ammonium salt)

Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
18:1 PE CF
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(carboxyfluorescein) (ammonium salt)
CAS Registry Number is a Registered Trademark of the American Chemical Society
Tang B, Peng Y, Yue Q, Pu Y, Li R, Zhao Y, Hai L, Guo L, Wu Y. Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer. Eur J Med Chem. 2020 May 1;193:112204. doi: 10.1016/j.ejmech.2020.112204. Epub 2020 Mar 5. PMID: 32172035.
PubMed ID: 32172035Wang Y, Yin S, Mei L, Yang Y, Xu S, He X, Wang M, Li M, Zhang Z, He Q. A dual receptors-targeting and size-switchable "cluster bomb" co-loading chemotherapeutic and transient receptor potential ankyrin 1 (TRPA-1) inhibitor for treatment of triple negative breast cancer. J Control Release. 2020 Feb 5;321:71-83. doi: 10.1016/j.jconrel.2020.02.010. Epub ahead of print. PMID: 32035191.
PubMed ID: 32035191Zhang Y, Heidari Z, Su Y, Yu T, Xuan S, Omarova M, Aydin Y, Dash S, Zhang D, John V. Amphiphilic Polypeptoids Rupture Vesicle Bilayers To Form Peptoid-Lipid Fragments Effective in Enhancing Hydrophobic Drug Delivery. Langmuir. 2019 Nov 26;35(47):15335-15343. doi: 10.1021/acs.langmuir.9b03322. Epub 2019 Nov 14.
PubMed ID: 31686512Pu Y, Zhang H, Peng Y, Fu Q, Yue Q, Zhao Y, Guo L, Wu Y. Dual-targeting liposomes with active recognition of GLUT5 and αvβ3 for triple-negative breast cancer. Eur J Med Chem. 2019 Sep 18;183:111720. doi: 10.1016/j.ejmech.2019.111720. [Epub ahead of print]
PubMed ID: 31553933Hajiahmadi F, Alikhani MY, Shariatifar H, Arabestani MR, Ahmadvand D. The bactericidal effect of lysostaphin coupled with liposomal vancomycin as a dual combating system applied directly on methicillin-resistant Staphylococcus aureus infected skin wounds in mice. Int J Nanomedicine. 2019 Jul 29;14:5943-5955. doi: 10.2147/IJN.S214521. eCollection 2019.
PubMed ID: 31447553Nienhaus F, Colley D, Jahn A, Pfeiler S, Flocke V, Temme S, Kelm M, Gerdes N, Flögel U, Bönner F. Phagocytosis of a PFOB-Nanoemulsion for 19F Magnetic Resonance Imaging: First Results in Monocytes of Patients with Stable Coronary Artery Disease and ST-Elevation Myocardial Infarction. Molecules. 2019 May 30;24(11). pii: E2058. doi: 10.3390/molecules24112058.
PubMed ID: 31151162Lu R, Zhou L, Yue Q, Liu Q, Cai X, Xiao W, Hai L, Guo L, Wu Y. Liposomes modified with double-branched biotin: A novel and effective way to promote breast cancer targeting. Bioorg Med Chem. 2019 May 28. pii: S0968-0896(19)30490-0. doi: 10.1016/j.bmc.2019.05.039. [Epub ahead of print]
PubMed ID: 31155297Guo X, Dong C, Liu Q, Zhu X, Zuo S, Zhang H. The sustained and targeted treatment of hemangiomas by propranolol-loaded CD133 aptamers conjugated liposomes-in-microspheres. Biomed Pharmacother. 2019 Jun;114:108823. doi: 10.1016/j.biopha.2019.108823. Epub 2019 Apr 6.
PubMed ID: 30965238Janke U, Kulke M, Buchholz I, Geist N, Langel W, Delcea M. Drug-induced activation of integrin alpha IIb beta 3 leads to minor localized structural changes. PLoS One. 2019 Apr 12;14(4):e0214969. doi: 10.1371/journal.pone.0214969. eCollection 2019.
PubMed ID: 30978226Saeed M, Zalba S, Seynhaeve ALB, Debets R, Ten Hagen TLM. Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response. Int J Nanomedicine. 2019 Mar 26;14:2069-2089. doi: 10.2147/IJN.S190736. eCollection 2019.
PubMed ID: 30988609Deshpande S, Brandenburg F, Lau A, Last MGF, Spoelstra WK, Reese L, Wunnava S, Dogterom M, Dekker C. Spatiotemporal control of coacervate formation within liposomes. Nat Commun. 2019 Apr 17;10(1):1800. doi: 10.1038/s41467-019-09855-x.
PubMed ID: 30996302Rao J, Mei L, Liu J, Tang X, Yin S, Xia C, Wei J, Wan D, Wang X, Wang Y, Li M, Zhang Z, He Q. Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention. Acta Biomater. 2019 Apr 15;89:300-312. doi: 10.1016/j.actbio.2019.03.022. Epub 2019 Mar 14.
PubMed ID: 30878446Yu Q, Qiu Y, Chen X, Wang X, Mei L, Wu H, Liu K, Liu Y, Li M, Zhang Z, He Q. Chemotherapy priming of the Pancreatic Tumor Microenvironment Promotes Delivery and Anti-Metastasis Efficacy of Intravenous Low-Molecular-Weight Heparin-Coated Lipid-siRNA Complex. Theranostics. 2019 Jan 1;9(2):355-368. doi: 10.7150/thno.29137. eCollection 2019.
PubMed ID: 30809279Wei J, Sun J, Liu Y. Enhanced targeting of prostate cancer-initiating cells by salinomycin-encapsulated lipid-PLGA nanoparticles linked with CD44 antibodies. Oncol Lett. 2019 Apr;17(4):4024-4033. doi: 10.3892/ol.2019.10050. Epub 2019 Feb 19.
PubMed ID: 30930999Shoji A, Takahashi Y, Osato S, Sugawara M. An enzyme-modified capillary as a platform for simultaneous fluorometric detection of d-glucose and l- lactate. J Pharm Biomed Anal. 2019 Jan 30;163:1-8. doi: 10.1016/j.jpba.2018.09.028. Epub 2018 Sep 19.
PubMed ID: 30268727Tang J, Wang Q, Yu Q, Qiu Y, Mei L, Wan D, Wang X, Li M, He Q. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery. Acta Biomater. 2019 Jan 1;83:379-389. doi: 10.1016/j.actbio.2018.11.002. Epub 2018 Nov 3.
PubMed ID: 30395963Dugger ME, Baker CA. Automated formation of black lipid membranes within a microfluidic device via confocal fluorescence feedback-controlled hydrostatic pressure manipulations. Anal Bioanal Chem. 2019 Jan 7. doi: 10.1007/s00216-018-1550-4. [Epub ahead of print]
PubMed ID: 30617393Bouvain P, Flocke V, Krämer W, Schubert R, Schrader J, Flögel U, Temme S. Dissociation of 19F and fluorescence signal upon cellular uptake of dual-contrast perfluorocarbon nanoemulsions. MAGMA. 2018 Nov 29. doi: 10.1007/s10334-018-0723-7. [Epub ahead of print]
PubMed ID: 30498884Pinon L, Montel L, Mesdjian O, Bernard M, Michel A, Ménager C, Fattaccioli J. Kinetically Enhanced Fabrication of Homogeneous Biomimetic and Functional Emulsion Droplets. Langmuir. 2018 Dec 18;34(50):15319-15326. doi: 10.1021/acs.langmuir.8b02721. Epub 2018 Dec 3.
PubMed ID: 30507132- Certificate of Analysis (Lot No. 810332C-10MG-A-037 and 5439CIA037)
- Certificate of Analysis (Lot No. 810332C-1MG-A-037 and 5439CGA037)
- Certificate of Analysis (Lot No. 810332C-5MG-A-037 and 5439CHA037)
- Certificate of Analysis (Lot No. 810332P-10MG-A-037 and 5439PIA037)
- Certificate of Analysis (Lot No. 810332P-1MG-A-037 and 5439PGA037)
- Certificate of Analysis (Lot No. 810332P-5MG-A-037 and 5439PHA037)
- Certificate of Analysis (Lot No. 810332C-1MG-A-038 and 5439CGA038)
- Certificate of Analysis (Lot No. 810332P-5MG-B-037 and 5439PHB037)
- Certificate of Analysis (Lot No. 810332P-10MG-A-038 and 5439PIA038)
- Certificate of Analysis (Lot No. 810332C-10MG-A-038 and 5439CIA038)
- Certificate of Analysis (Lot No. 810332P-1MG-A-038 and 5439PGA038)
- Certificate of Analysis (Lot No. 810332C-5MG-A-038 and 5439CHA038)
- Certificate of Analysis (Lot No. 810332P-5MG-A-038 and 5439PHA038)
- Certificate of Analysis (Lot No. 810332C-1MG-B-038 and 5439CGB038)
- Certificate of Analysis (Lot No. 810332C-1MG-C-038 and 5439CGC038)
- Certificate of Analysis (Lot No. 810332P-1MG-B-038 and 5439PGB038)
- Certificate of Analysis (Lot No. 810332C-1MG-D-038 and 5439CGD038)
- Certificate of Analysis (Lot No. 810332P-10MG-B-038 and 5439PIB038)
- Certificate of Analysis (Lot No. 810332P-5MG-B-038 and 5439PHB038)
- Certificate of Analysis (Lot No. 810332P-1MG-C-038 and 5439PGC038)
- Certificate of Analysis (Lot No. 810332C-5MG-B-038 and 5439CHB038)
- Certificate of Analysis (Lot No. 810332C-1MG-E-038 and 5439CGE038)
- Certificate of Analysis (Lot No. 810332C-5MG-C-038 and 5439CHC038)
- Certificate of Analysis (Lot No. 810332C-1MG-F-038 and 5439CGF038)
- Certificate of Analysis (Lot No. 810332C-5MG-E-038 and 5439CHE038)
- Certificate of Analysis (Lot No. 810332P-5MG-C-038 and 5439PHC038)
- Certificate of Analysis (Lot No. 810332P-1MG-D-038 and 5439PGD038)
- Certificate of Analysis (Lot No. 810332P-5MG-D-038 and 5439PHD038)
- Certificate of Analysis (Lot No. 810332P-5MG-E-038 and 5439PHE038)
- Certificate of Analysis (Lot No. 810332P-1MG-E-038 and 5439PGE038)
- Certificate of Analysis (Lot No. 810332P-5MG-F-038 and 5439PHF038)
- Certificate of Analysis (Lot No. 810332C-1MG-G-038 and 5439CGG038)
- Certificate of Analysis (Lot No. 810332P-10MG-D-038 and 5439PID038)
- Certificate of Analysis (Lot No. 810332C-1MG-H-038 and 5439CGH038)
- Certificate of Analysis (Lot No. 810332P-10MG-E-038 and 5439PIE038)
- Certificate of Analysis (Lot No. 810332P-5MG-G-038 and 5439PHG038)